Sandbox:Dhiran: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
*AMI-CS | *AMI-CS | ||
*AMI-CS and concomitant | *AMI-CS and concomitant C | ||
===Heart Failure-=== | ===Heart Failure- === | ||
* patients with HFpEF | |||
* pateints with HFrEF | |||
* *** patients with non | |||
* | |||
===Myocarditis -ddddddddddddddddddd<nowiki><br></nowiki>=== | ===Myocarditis -ddddddddddddddddddd<nowiki><br></nowiki>=== | ||
Revision as of 05:17, 17 January 2021
Management
AMI - prompt PCI
- AMI-CS
- AMI-CS and concomitant C
Heart Failure-
- patients with HFpEF
- pateints with HFrEF
- *** patients with non
Myocarditis -ddddddddddddddddddd<br>
ddddddddddddddddddddddddddddddddddddddddfkjalsdkjflkdsaflkjadsflkjadsl
Prognosis
The outcome of patients with AMI-CS depends on the duration of the shock and the metabolic derangements noted.